foreign ownership

Steve Carter is in San Francisco for the Biotech Conference which starts tonight our time . That is where the sophisticated biotech investors are . Now he has those hard results , from UWA , proving the 002 can be used with any of the budding cancer vaccines in developement , because unlike the other chemos it does not suppress the immune system , dont be surprised if he picks up some good offers from the companies waiting to meet him there .
Three years leadup time to clinical trials is quick . Look at Aegera , which is 2 months behind Solbec after 10 years research .